As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(781)535-1428
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
We provide a complete range of custom monoclonal antibody development services, from antigen design and production to humanized antibodies. We will use an antigen that you supply, or we can produce it for you, either as a recombinant protein or a chemically synthesized peptide.
Medicilon's antibody development technical service discount covers the full line of ADA antibody development technical services and druggable antibody development technical services. The 20% off discount applies to the completion of ADA rabbit polyclonal antibody development, ADA mouse hybridoma monoclonal antibody development, phage display rabbit monoclonal antibody development services, mouse monoclonal antibody development technical services, mouse/rabbit single B cell antibody development technical services, etc.
Some of the Stand-Alone Services We Provide Include
Antigen Design and Production
Immunizations
Hybridoma Development
Hybridoma Cell Culturing and Antibody Purification
Antibody cDNA Sequencing
Antibody Isotype Switching
Antibody Chimerisation
Transient Expression of Monoclonal Antibodies
Program Features
Capabilities to develop fully human MAbs using OMT’s transgenic OmniRat™ and ffOmniMouse™ technologies
Human MAb phage display technology platforms
Custom phage display library generation
Exceptionally high cell fusion rates for the creation of hybridomas
High-throughput analysis of MAb pools
A wide array of in-vitro and in-vivo antibody screening and characterization assays
AAALAC-accredited animal facility
Reliable, cost-effective solutions with global access to the world’s fastest-growing healthcare markets
Proven target-to-lead capabilities
Full range of services from discovery to commercialization
World-class advanced hybridoma technology platforms for therapeutic MAb discovery
State-of-the-art laboratory and manufacturing facilities (GMP and non-GMP)
Our Antibody Competitive Advantages
Rapid Development of Antibodies
High Content mAB Development
High-Affinity Antibody Development
High Success Rate
mAB Development to Difficult and Rare Epitopes
High Throughput Robotic Automation
Depth Discussion and Understanding of Customer Needs
Highly Trained and Experienced Staff
Comprehensive Services
It is always early enough to start planning for antibody development. A carefully planned antibody development strategy almost always provides good results. Before starting antigen preparation, you must have a well-defined screening strategy. Please start talking to us when you anticipate the need to develop antibodies for your target. We will work with you to create the antibody reagent you need.
Scientists at our R&D department are continually improving our state-of-the-art proprietary technology to achieve the cost-effective development of quality antibodies to serve you better.
Email: marketing@medicilon.com
Tel : +86 021 58591500
Tips: Above is part of antibody development services, monoclonal antibody services, and antibody development costs. You can also CONTACT US with any question or inquiry you may have. We will be happy to discuss your needs and design an appropriate action plan.
Relevant
news
marketing@medicilon.com
ABOUT
